Diagnostic and Interventional Cardiology - DAIC

  • Home
  • Diagnostic and Interventional Cardiology - DAIC

Diagnostic and Interventional Cardiology - DAIC DAIC and www.dicardiology.com showcase new and emerging technology and devices for cardiology depart

DAIC magazine connects cardiology departments with the latest products cleared by the FDA, news from ongoing clinical trials and offers information to aid in purchasing decisions. DAIC provides product comparison charts, overviews of how newer technology works and stories about how end-users have solved problems, increase workflow and improved patient outcomes using various technology.

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work fr...
02/07/2025

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work from anywhere at any time. Available from Core Sound Imaging

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work from anywhere at any time. Available from Core Sound Imaging, Studycast provides an intuitive workflow from viewing images to creating reports to archiving exams. Its cloud-based s...

Renowned cardiovascular geneticist and Harvard Medical School professor honored for groundbreaking research and lifelong...
05/05/2025

Renowned cardiovascular geneticist and Harvard Medical School professor honored for groundbreaking research and lifelong commitment to advancing heart health.

The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician-scientist and pioneer in cardiovascular genetics, has been selected as the recipient of the 2025 Paul Dudley White Award. The award, established in 1974, is presented annually to a....

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits dow...
31/07/2024

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity.

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical devi...

BioCardia has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath.
31/07/2024

BioCardia has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath.

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, reported it has submitted a 510(k) for approval of its patented Morph DNA Steerable Introducer Sheath. This product family is intended to provide a pat...

A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute,...
31/07/2024

A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF).

July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF). The study...

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from Se...
31/07/2024

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA.

July 30, 2024 — The Heart Rhythm Society (HRS) is preparing for HRX 2024, bringing cardiovascular health innovators to Georgia's capital. HRX is an unconventional convening of clinicians, engineers, developers, researchers, entrepreneurs, and investors inspiring collaborative generation of ideas a...

Magenta Medical, developer of Elevate, the world's smallest heart pump, has closed a $105M financing round led by global...
30/07/2024

Magenta Medical, developer of Elevate, the world's smallest heart pump, has closed a $105M financing round led by global healthcare investment firm Novo Holdings.

July 29, 2024 — Magenta Medical, developer of Elevate, the world's smallest heart pump, has closed a $105M financing round led by global healthcare investment firm Novo Holdings. New investors Viking Global Investors and RA Capital Management, and existing investors OrbiMed, New Enterprise Associa...

CorVascular announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical...
30/07/2024

CorVascular announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical devices.

July 29, 2024 — CorVascular, a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) testing devices, today announced the U.S. Food and Drug Administration (FDA) has cleared its VasoGuard V-Series as Class II medical devices. The clearance allows CorVascular to ...

Researchers from Osaka Metropolitan University have developed a new scoring model, using only prehospital resuscitation ...
30/07/2024

Researchers from Osaka Metropolitan University have developed a new scoring model, using only prehospital resuscitation data, that accurately predicts neurological outcomes of patients with out-of-hospital cardiac arrest (OHCA).

July 29, 2024 — When it comes to treating cardiac arrest, acting quickly can mean the difference between life and death. Researchers from Osaka Metropolitan University have developed a new scoring model, using only prehospital resuscitation data, that accurately predicts neurological outcomes of p...

Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aorti...
30/07/2024

Edwards has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation (AR), a deadly disease that impacts a significant and growing population and is largely untreated today.

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. Edwards has entered into an agreement to acquire ...

VentriJect has been invited to the United Nations General Assembly (UNGA) in New York to demonstrate Seismofit, its port...
29/07/2024

VentriJect has been invited to the United Nations General Assembly (UNGA) in New York to demonstrate Seismofit, its portable and fast VO2 max estimation solution.

July 26, 2024 — VentriJect, a Danish medtech start-up seeking to revolutionize the way cardiorespiratory fitness (CRF) is measured, has been invited to the United Nations General Assembly (UNGA) in New York to demonstrate Seismofit, its portable and fast VO2 max estimation solution. The demonstrat...

BioCardia announced that the confirmatory Phase 3 trial of its autologous CardiAMP cell therapy product candidate for pa...
29/07/2024

BioCardia announced that the confirmatory Phase 3 trial of its autologous CardiAMP cell therapy product candidate for patients with ischemic heart failure of reduced ejection fraction (HFrEF) has commenced enrollment in the US.

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that the confirmatory Phase 3 trial of its autologous CardiAMP cell therapy product candidate for patients with ischemic heart fail...

Address


Website

Alerts

Be the first to know and let us send you an email when Diagnostic and Interventional Cardiology - DAIC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Diagnostic and Interventional Cardiology - DAIC:

Shortcuts

  • Address
  • Alerts
  • Contact The Business
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share

Our Story

Diagnostic and Interventional Cardiology (DAIC) provides healthcare professionals in cardiology, interventional cardiology, cardiovascular imaging, cardiac diagnostics, cardiac catheterization and electrophysiology departments with vital information required to make informed purchasing decisions, gain greater efficiencies, and achieve successful outcomes for their patients. DAIC brand content and editorial scope includes new and emerging technologies, case studies and white papers, clinical trial updates, online webinars and education, product comparison charts, business and economics updates, industry news and trends, and special supplements. DAIC editorial content is also available to a global audience via an online digital edition, web site, e-newsletters, pulseTV video and through multiple social media channels.

To subscribe to DAIC’s print or digital edition, please visit: https://www.cdsreportnow.com/renew/now?dic

To subscribe to DAIC’s e-newsletters, please visit: https://www.dicardiology.com/subscription-management